WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the Fourth Annual Noble Financial Equity Conference on Monday, August 18, 2008 at the Loews Lake Las Vegas, Nevada. The Company’s President and CEO, Steven Rauscher, will provide an overview of the Company; highlight details on the recent market performance of ANTARA® (fenofibrate) capsules and FACTIVE® (gemifloxacin mesylate) tablets; and discuss the Company’s recently announced results for the second quarter of 2008, in which Oscient recorded $20.3 million in revenues.
